ClinicalTrials.Veeva

Menu

Kinesiophobia Scale for the Upper Extremity

E

Emre Şenocak

Status

Enrolling

Conditions

Shoulder Injuries

Study type

Observational

Funder types

Other

Identifiers

NCT06485934
2024/74

Details and patient eligibility

About

Questionnaires/scales used to evaluate kinesiophobia in the literature are limited and are not specific to the upper extremity in existing scales. For this reason, the primary purpose and subject of the study is to develop a multi-factor kinesiophobia scale specific to shoulder problems.

The study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Tampa Kinesiophobia Score >37 points
  • Presence of traumatological, orthopedic and rheumatological pathology in the upper extremity
  • Mini-Mental State Examination score >24 points

Exclusion criteria

  • Malignancy,
  • Psychiatric drug use,
  • Use of painkillers during evaluation periods,
  • Those who received physiotherapy before the study (last 6 months),
  • Those whose education level is below secondary school level,

Trial design

150 participants in 1 patient group

Observational Group
Description:
All of the outcomes will be applied to patients who come to the outpatient clinic due to shoulder problems. Then, 1 week later, participants will be recalled to apply the multidimensional kinesiophobia scale a second time.

Trial contacts and locations

2

Loading...

Central trial contact

Aysel Yıldız Özer, Professor; Emre Şenocak, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems